Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Conditions
Medullary Thyroid Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Anhui Provincial Cancer Hospital, Hefei, Anhui, China
Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing, Beijing Municipality, China
Gansu Cancer Hospital, Lanzhou, Gansu, China
Guangxi Zhuang Autonomous Region Cancer Hospital (Affiliated Cancer Hospital of Guangxi Medical University), Nanning, Guangxi, China
The First Affiliated Hospital of Hebei North University, Shijiazhuang, Hebei, China
Tianjin Cancer Hospital, Tianjin, Hebei, China
Henan Cancer Hospital, Zhengzhou, Henan, China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Hubei Cancer Hospital, Wuhan, Hubei, China
Hunan Cancer Hospital, Changsha, Hunan, China
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University, Nanjing, Jiangsu, China
Jiangsu North People's Hospital, Yangzhou, Jiangsu, China
Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China
The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an, Shanxi, China
Shanxi Provincial Tumor Hospital, Xi’an, Shanxi, China
Tianjin People's Hospital, Tianjin, Tianjin Municipality, China
The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China